Suppr超能文献

皮下植入式除颤器在运动员中的长期性能:来自iSUSI注册中心的多中心、真实世界体育活动分析。

Long-term performance of subcutaneous implantable defibrillators in athletes: A multicenter, real-world analysis of sport activities from the iSUSI registry.

作者信息

Gasperetti Alessio, Schiavone Marco, Vogler Julia, Compagnucci Paolo, Laredo Mikael, Breitenstein Alexander, Gulletta Simone, Martinek Martin, Kaiser Lukas, Lavalle Carlo, Gaine Sean, Santini Luca, Dello Russo Antonio, Palmisano Pietro, Rovaris Giovanni, Curnis Antonio, Ventrella Nicoletta, Kuschyk Jürgen, Biffi Mauro, Tilz Roland, Di Biase Luigi, Tondo Claudio, Forleo Giovanni B

机构信息

Department of Cardiology, Johns Hopkins University, Baltimore, Maryland, USA.

Department of Clinical Electrophysiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

出版信息

Heart Rhythm. 2025 Jul;22(7):1782-1789. doi: 10.1016/j.hrthm.2024.09.039. Epub 2024 Sep 20.

Abstract

BACKGROUND

No data regarding subcutaneous-implantable cardioverter defibrillator (S-ICD) technology in patients actively engaging in sports activities are available.

OBJECTIVE

This study aims to compare S-ICD performance between athletes and nonathletes.

METHODS

The primary outcome of the study was the comparison of overall device-related complications between athletes and nonathletes. Appropriate shocks, inappropriate shocks, and individual device-related complications were secondary outcomes.

RESULTS

A total of 1493 patients were extracted from the International Subcutaneous Implantable Cardioverter Defibrillator Registry (iSUSI) registry, of whom 152 (10.2%) were athletes, mostly engaging in dynamic sports (54.2%). Brugada syndrome, myocarditis, and arrhythmogenic right ventricular cardiomyopathy (ARVC) were more common in athletes (11.2% vs 3.3%, P < .001; 19.1% vs 9.0%, P < .001; 8.6% vs 2.8%, P < .001, respectively). During a median follow-up time of 25.5 (12.0-41.2) months, athletes were more likely to experience appropriate shocks (yearly rate: 7.2 [4.9-10.7] % vs 4.3 [3.6-5.1] %, P = .028), occurring more frequently during exercise (3.9% vs 0.6%, P < .001). This finding lost significance when adjusting for confounders (adjusted hazard ratio [aHR] 1.440 [0.909-2.281], P = .120). No differences were found in overall device-related complications (yearly rate: 3.3% vs 3.4%, P = .448) and inappropriate shocks (yearly rate: 5.3% vs 3.7%, P = 0.111). Myopotential oversensing (4.0% vs 1.3%, P = .011) was more common in athletes, as were lead infections (3.3% vs 0.9%, P =.008), with the latter clustering in the early postimplantation period.

CONCLUSION

The S-ICD is a valid therapeutic option for preventing sudden cardiac death in athletes. Sports practice was not associated with an increased risk of complications or inappropriate shocks, although athletes are exposed to a higher risk of S-ICD infections in the early postoperative period.

摘要

背景

目前尚无关于积极参与体育活动的患者使用皮下植入式心律转复除颤器(S-ICD)技术的数据。

目的

本研究旨在比较运动员和非运动员使用S-ICD的性能。

方法

本研究的主要结局是比较运动员和非运动员之间与设备相关的总体并发症。适当电击、不适当电击以及个体与设备相关的并发症为次要结局。

结果

从国际皮下植入式心律转复除颤器注册中心(iSUSI)注册库中提取了1493例患者,其中152例(10.2%)为运动员,大多数从事动态运动(54.2%)。Brugada综合征、心肌炎和致心律失常性右室心肌病(ARVC)在运动员中更为常见(分别为11.2%对3.3%,P<.001;19.1%对9.0%,P<.001;8.6%对2.8%,P<.001)。在中位随访时间25.5(12.0 - 41.2)个月期间,运动员更有可能经历适当电击(年发生率:7.2[4.9 - 10.7]%对4.3[3.6 - 5.1]%,P = .028),在运动期间发生频率更高(3.9%对0.6%,P<.001)。在对混杂因素进行调整后,这一发现失去了显著性(调整后风险比[aHR]为1.440[0.909 - 2.281],P = .120)。在与设备相关的总体并发症(年发生率:3.3%对3.4%,P = .448)和不适当电击(年发生率:5.3%对3.7%,P = 0.111)方面未发现差异。肌电位过度感知在运动员中更常见(4.0%对1.3%,P = .011),导线感染也是如此(3.3%对0.9%,P = .008),后者在植入后早期聚集。

结论

S-ICD是预防运动员心脏性猝死的有效治疗选择。体育活动与并发症或不适当电击风险增加无关,尽管运动员在术后早期面临S-ICD感染的较高风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验